Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
New
Healthcare professionals (HCPs) are turning to biopharmas to help distill rapidly evolving scientific evidence around new innovative medicines and complex diseases. By focusing pre-launch activity around clinical guidelines, publications, and congresses with a new group of stakeholders, medical affairs teams can reach key HCPs to improve treatment decisions.
"Gone are the days when medical could just focus on the top-tier scientific thought leaders," said
The latest analysis from Veeva Pulse finds that:
- Targeted pre-launch scientific activities speed treatment adoption: By engaging key experts at congresses, helping develop clinical guidelines, and securing coverage in publications before launch, companies see 40% faster treatment adoption than those that invest less in this outreach. This demonstrates that more resources for medical teams during this stage can boost launch success.
-
Congress activity has the strongest influence on clinical decisions: Higher investment in pre-launch congress activities has the most influence on treatment after approval. Congresses, and the digital discussions that follow, help increase scientific awareness and drive impactful medical conversations more than investment in clinical guidelines and publications. - Engaging early-career HCPs increases new treatment uptake: These digitally-savvy emerging experts are four times more likely to start patients on a new treatment. They are also five times more likely to speak at congresses, 11 times more likely to engage digitally, and seven times more likely to get published.
"As HCPs gain an increasing amount of information to understand complex new medicines across channels, effectively communicating scientific evidence before launch can make all the difference," said
About the Veeva Pulse Field Trends Report
Analyzing over 600 million HCP interactions and activities annually from more than 80% of commercial biopharma field teams worldwide, the Veeva Pulse Field Trends Report is the largest industry benchmark of its kind on HCP engagement. The analysis compiles real-time transactional data recorded in Veeva CRM and
Additional Information
To download a copy of the Veeva Pulse Field Trends Report, visit: veeva.com/FieldTrends
Learn more about
Connect with
About
Veeva Forward-looking Statements
This release contains forward-looking statements regarding
Contact:
925-226-8821
alison.borris@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/targeted-pre-launch-scientific-outreach-drives-40-faster-treatment-adoption-302206400.html
SOURCE